Add like
Add dislike
Add to saved papers

"A Flow Dynamic Rationale for Accelerated Vascularized Composite Allotransplant Rejection".

BACKGROUND: From 1996 to 2000 Diefenbeck et al. carried out 6 knee vascularized composite allotransplants(VCA). The VCAs were composed of bone, soft tissue, and the femoral vascular pedicle (25-40 cm total length). All rejected between 14 to 56 months. The failures were attributed to chronic rejection (CR). In 2008 the Louisville team lost their fourth patient's hand transplant at 8 months. During the rejection workup the senior surgeon's intra-operative findings noted a thickened arterial pedicle attributed to intimal hyperplasia (IH) with significant fibrotic perivascular tissue and a near 'no flow phenomenon'. No cutaneous rejection was appreciated and failure was attributed to CR.

METHODS: Data was collected from two teams, one in Germany and the other in Louisville. The population under study was the six knee and one hand VCA. The factor of interest was the long donor arterial pedicle. The outcome measurements were the VCA survival time and histopathological results.

RESULTS: There are only seven published VCA cases where a donor artery >25cm was used. This cohort represents a 100% accelerated failure rate. The etiology of these VCA losses remains unexplained. The donor arteries suffered from TCMR and ischemia induced media/adventitial necrosis.

CONCLUSION: We hypothesize the donor artery rejected at an accelerated rate due to ischemia caused by disruption of the external vasa vasorum in conjunction with TCMR induced IH which lead to disruption of the Windkessel Effect. The loss of this Effect presented as IH accelerated by ischemia causing an expedited VCA failure.This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app